111 related articles for article (PubMed ID: 25536525)
1. Phosphate modulates receptor sulfotyrosine recognition by the chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2).
Ludeman JP; Nazari-Robati M; Wilkinson BL; Huang C; Payne RJ; Stone MJ
Org Biomol Chem; 2015 Feb; 13(7):2162-9. PubMed ID: 25536525
[TBL] [Abstract][Full Text] [Related]
2. Homogeneous sulfopeptides and sulfoproteins: synthetic approaches and applications to characterize the effects of tyrosine sulfation on biochemical function.
Stone MJ; Payne RJ
Acc Chem Res; 2015 Aug; 48(8):2251-61. PubMed ID: 26196117
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).
Tan JHY; Ludeman JP; Wedderburn J; Canals M; Hall P; Butler SJ; Taleski D; Christopoulos A; Hickey MJ; Payne RJ; Stone MJ
J Biol Chem; 2013 Apr; 288(14):10024-10034. PubMed ID: 23408426
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.
Seibert C; Sanfiz A; Sakmar TP; Veldkamp CT
Methods Enzymol; 2016; 570():357-88. PubMed ID: 26921955
[TBL] [Abstract][Full Text] [Related]
5. The structural role of receptor tyrosine sulfation in chemokine recognition.
Ludeman JP; Stone MJ
Br J Pharmacol; 2014 Mar; 171(5):1167-79. PubMed ID: 24116930
[TBL] [Abstract][Full Text] [Related]
6. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents.
David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS
Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817
[TBL] [Abstract][Full Text] [Related]
7. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.
Ziarek JJ; Getschman AE; Butler SJ; Taleski D; Stephens B; Kufareva I; Handel TM; Payne RJ; Volkman BF
ACS Chem Biol; 2013 Sep; 8(9):1955-63. PubMed ID: 23802178
[TBL] [Abstract][Full Text] [Related]
8. Toward a framework for sulfoproteomics: Synthesis and characterization of sulfotyrosine-containing peptides.
Seibert C; Sakmar TP
Biopolymers; 2008; 90(3):459-77. PubMed ID: 17680702
[TBL] [Abstract][Full Text] [Related]
9. Specificity determinants for chemokine recognition identified using eotaxin-MCP-1 chimeras.
Mayer MR; Parody TR; Datta-Mannan A; Stone MJ
FEBS Lett; 2004 Jul; 571(1-3):166-70. PubMed ID: 15280036
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine sulfation influences the chemokine binding selectivity of peptides derived from chemokine receptor CCR3.
Zhu JZ; Millard CJ; Ludeman JP; Simpson LS; Clayton DJ; Payne RJ; Widlanski TS; Stone MJ
Biochemistry; 2011 Mar; 50(9):1524-34. PubMed ID: 21235238
[TBL] [Abstract][Full Text] [Related]
11. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.
Simpson LS; Zhu JZ; Widlanski TS; Stone MJ
Chem Biol; 2009 Feb; 16(2):153-61. PubMed ID: 19246006
[TBL] [Abstract][Full Text] [Related]
12. Identification of CCR2-binding features in Cytl1 by a CCL2-like chemokine model.
Tomczak A; Pisabarro MT
Proteins; 2011 Apr; 79(4):1277-92. PubMed ID: 21322034
[TBL] [Abstract][Full Text] [Related]
13. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
[TBL] [Abstract][Full Text] [Related]
15. Design and receptor interactions of obligate dimeric mutant of chemokine monocyte chemoattractant protein-1 (MCP-1).
Tan JH; Canals M; Ludeman JP; Wedderburn J; Boston C; Butler SJ; Carrick AM; Parody TR; Taleski D; Christopoulos A; Payne RJ; Stone MJ
J Biol Chem; 2012 Apr; 287(18):14692-702. PubMed ID: 22396538
[TBL] [Abstract][Full Text] [Related]
16. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
17. The Synthesis of Sulfated CCR5 Peptide Surrogates and their Use to Study Receptor-Ligand Interactions.
Naider F; Anglister J
Protein Pept Lett; 2018; 25(12):1124-1136. PubMed ID: 30381052
[TBL] [Abstract][Full Text] [Related]
18. Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
Møller AS; Øvstebø R; Westvik AB; Joø GB; Haug KB; Kierulf P
J Endotoxin Res; 2003; 9(6):349-60. PubMed ID: 14733721
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins.
Stone MJ; Chuang S; Hou X; Shoham M; Zhu JZ
N Biotechnol; 2009 Jun; 25(5):299-317. PubMed ID: 19658209
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of polymers and nanoparticles bearing polystyrene sulfonate brushes for chemokine binding.
Isahak N; Sanchez J; Perrier S; Stone MJ; Payne RJ
Org Biomol Chem; 2016 Jun; 14(24):5652-8. PubMed ID: 27031327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
